Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients
Authors:
Top Cited Papers
- 1 January 2014
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 73 (1) , 227-232
Abstract
Objective To compare the cumulative survival and event free survival in patients with Jo-1 versus non-Jo-1 anti-tRNA synthetase autoantibodies (anti-synAb). Methods Anti-synAb positive patients initially evaluated from 1985 to 2009 were included regardless of the connective tissue disease (CTD) diagnosis. Clinical data were extracted from a prospectively collected database and chart review. Survival between Jo-1 and non-Jo-1 was compared by log rank and Cox proportional hazards methods. Results 202 patients possessed anti-synAb: 122 Jo-1 and 80 non-Jo-1 (35 PL-12; 25 PL-7; 9 EJ; 6 KS; 5 OJ). The diagnoses at first visit for Jo-1 and non-Jo-1 patients were myositis in 83% and 40.0%, overlap or undifferentiated CTD in 17% and 47.5%, and systemic sclerosis in 0% and 12.5%, respectively (pConclusions Non-Jo-1 anti-synAb positive patients have decreased survival compared with Jo-1 patients. The difference in survival may be partly attributable to a delay in diagnosis in the non-Jo-1 patients.Keywords
This publication has 31 references indexed in Scilit:
- Severe pulmonary hypertension in Anti–Jo‐1 syndromeArthritis Care & Research, 2010
- Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumoniaRespiratory Medicine, 2009
- Characterization and peripheral blood biomarker assessment of anti–Jo‐1 antibody–positive interstitial lung diseaseArthritis & Rheumatism, 2009
- Clinical characteristics of Japanese patients with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibodiesRheumatology, 2007
- Clinical and immunogenetic features of patients with autoantibodies to asparaginyl–transfer RNA synthetaseArthritis & Rheumatism, 2007
- Predicting Factors of Interstitial Lung Disease in Dermatomyositis and PolymyositisActa Dermato-Venereologica, 2007
- Clinical implications of autoantibody screening in patients with autoimmune myositisAutoimmunity, 2006
- Survival, mortality and causes of death in inflammatory myopathiesAutoimmunity, 2006
- Pulmonary Manifestations of Polymyositis/DermatomyositisClinical Pulmonary Medicine, 2006
- A comparison between anti‐Th/To– and anticentromere antibody–positive systemic sclerosis patients with limited cutaneous involvementArthritis & Rheumatism, 2003